Clinical Trials · NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 1,481
- Start date
- Nov 2023
- Locations
- 53 sites, United States, Argentina
- Primary endpoint
- Number of Participants Allocated to Each ISA